Christel Larbouret

1.3k total citations
36 papers, 971 citations indexed

About

Christel Larbouret is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Christel Larbouret has authored 36 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 22 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in Christel Larbouret's work include HER2/EGFR in Cancer Research (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Christel Larbouret is often cited by papers focused on HER2/EGFR in Cancer Research (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Christel Larbouret collaborates with scholars based in France, Switzerland and United Kingdom. Christel Larbouret's co-authors include André Pèlegrin, Bruno Robert, D. Azria, Thierry Chardès, Nadège Gaborit, Marta Jarlier, Caroline Mollévi, Wilhem Leconet, Jean‐Pierre Mach and Pierre Martineau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Christel Larbouret

35 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christel Larbouret France 18 652 366 356 224 128 36 971
Joshua Z. Drago United States 9 742 1.1× 356 1.0× 454 1.3× 95 0.4× 255 2.0× 28 1.1k
Ecaterina E. Dumbrava United States 17 647 1.0× 379 1.0× 171 0.5× 185 0.8× 218 1.7× 115 1.0k
A. Lambiase Italy 17 613 0.9× 297 0.8× 146 0.4× 102 0.5× 181 1.4× 55 899
Dietmar Berndorff Germany 14 326 0.5× 538 1.5× 548 1.5× 97 0.4× 76 0.6× 18 1.0k
Kim Pedersen Spain 12 761 1.2× 351 1.0× 449 1.3× 113 0.5× 112 0.9× 14 992
Nadège Gaborit France 18 449 0.7× 370 1.0× 264 0.7× 68 0.3× 156 1.2× 24 773
Arris J. Henderson United States 8 424 0.7× 454 1.2× 320 0.9× 94 0.4× 128 1.0× 8 1.0k
Michael V. Grandal Denmark 12 365 0.6× 564 1.5× 180 0.5× 122 0.5× 89 0.7× 13 897
Anton G.T. Terwisscha van Scheltinga Netherlands 19 460 0.7× 293 0.8× 507 1.4× 67 0.3× 247 1.9× 30 1.0k
K. Papadopoulos United States 16 540 0.8× 598 1.6× 121 0.3× 299 1.3× 215 1.7× 56 1.1k

Countries citing papers authored by Christel Larbouret

Since Specialization
Citations

This map shows the geographic impact of Christel Larbouret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christel Larbouret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christel Larbouret more than expected).

Fields of papers citing papers by Christel Larbouret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christel Larbouret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christel Larbouret. The network helps show where Christel Larbouret may publish in the future.

Co-authorship network of co-authors of Christel Larbouret

This figure shows the co-authorship network connecting the top 25 collaborators of Christel Larbouret. A scholar is included among the top collaborators of Christel Larbouret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christel Larbouret. Christel Larbouret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garambois, Véronique, Christel Larbouret, Laurie Lajoie, et al.. (2023). Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer. Frontiers in Immunology. 14. 1168444–1168444. 6 indexed citations
2.
Garambois, Véronique, Nelly Pirot, Charles Theillet, et al.. (2021). Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models. mAbs. 13(1). 1914883–1914883. 7 indexed citations
3.
Larbouret, Christel, Laurent Gros, André Pèlegrin, & Thierry Chardès. (2021). Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures. Cancers. 13(18). 4620–4620. 11 indexed citations
4.
Garambois, Véronique, Nadège Gaborit, Christel Larbouret, et al.. (2020). Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking. Cancer Science. 111(7). 2508–2525. 3 indexed citations
5.
Fraisse, Julien, Marta Jarlier, Florence Boissière‐Michot, et al.. (2020). Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells. International Journal of Radiation Oncology*Biology*Physics. 106(5). 1039–1051. 8 indexed citations
6.
Clorennec, Christophe Le, Yassamine Lazrek, Olivier Dubreuil, et al.. (2019). ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells. Cell Communication and Signaling. 17(1). 106–106. 13 indexed citations
7.
Larbouret, Christel, Marie‐Alix Poul, & Thierry Chardès. (2019). Imiter la réponse immunitaire humorale polyclonale. médecine/sciences. 35(12). 1083–1091. 1 indexed citations
8.
Bryden, Francesca, Cyril Colas, Émilie Allard-Vannier, et al.. (2018). Impact of cathepsin B-sensitive triggers and hydrophilic linkers onin vitroefficacy of novel site-specific antibody–drug conjugates. Organic & Biomolecular Chemistry. 16(11). 1882–1889. 36 indexed citations
9.
Clorennec, Christophe Le, Hervé Bazin, Olivier Dubreuil, et al.. (2017). Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3. Molecular Cancer Therapeutics. 16(7). 1312–1323. 13 indexed citations
10.
Leconet, Wilhem, Stanislas du Manoir, Clément Chevalier, et al.. (2016). Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis. Clinical Cancer Research. 23(11). 2806–2816. 87 indexed citations
11.
Marzi, Laetitia, Nadia Vié, Diégo Tosi, et al.. (2016). FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer. British Journal of Cancer. 115(10). 1223–1233. 44 indexed citations
12.
Gaborit, Nadège, Ali Abdul‐Hai, Maicol Mancini, et al.. (2015). Examination of HER3 targeting in cancer using monoclonal antibodies. Proceedings of the National Academy of Sciences. 112(3). 839–844. 35 indexed citations
13.
Leconet, Wilhem, Christel Larbouret, Thierry Chardès, et al.. (2013). Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Oncogene. 33(47). 5405–5414. 81 indexed citations
14.
Ho-Pun-Cheung, Alexandre, Hervé Bazin, Nadège Gaborit, et al.. (2012). Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer. PLoS ONE. 7(7). e37065–e37065. 21 indexed citations
15.
Gaborit, Nadège, Christel Larbouret, Frédéric Peyrusson, et al.. (2011). Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers. Journal of Biological Chemistry. 286(13). 11337–11345. 58 indexed citations
16.
Larbouret, Christel, Bruno Robert, Caroline Mollévi, et al.. (2009). Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. Annals of Oncology. 21(1). 98–103. 40 indexed citations
17.
Larbouret, Christel, et al.. (2007). [Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment].. PubMed. 94(10). 860–2. 1 indexed citations
18.
Larbouret, Christel, Bruno Robert, Christine Linard, et al.. (2007). Radiocurability by Targeting Tumor Necrosis Factor-α Using a Bispecific Antibody in Carcinoembryonic Antigen Transgenic Mice. International Journal of Radiation Oncology*Biology*Physics. 69(4). 1231–1237. 11 indexed citations
19.
Azria, D., Christel Larbouret, Séverine Cunat, et al.. (2004). Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Research. 7(1). R156–63. 58 indexed citations
20.
Azria, D., Christel Larbouret, Bruno Robert, et al.. (2003). [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].. PubMed. 90 Spec No. S202–12. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joshua Z. Drago Breakdown of academic impact, for papers by Ecaterina E. Dumbrava Breakdown of academic impact, for papers by A. Lambiase Breakdown of academic impact, for papers by Dietmar Berndorff Breakdown of academic impact, for papers by Kim Pedersen Breakdown of academic impact, for papers by Nadège Gaborit Breakdown of academic impact, for papers by Arris J. Henderson Breakdown of academic impact, for papers by Michael V. Grandal Breakdown of academic impact, for papers by Anton G.T. Terwisscha van Scheltinga Breakdown of academic impact, for papers by K. Papadopoulos
Rankless by CCL
2026